Regulation of Na+,K+-ATPase activity by dopamine in cultured rat aortic smooth muscle cells

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 223-230

  Rashed, Sahar M K ^a   Songu Mize, Emel ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

dopamine; dopamine receptor; dopamine signal transduction; Na+,K+ ATPase, activity; rat; smooth muscle cell, aortic; smooth muscle, vascular

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE DERIVATIVE; HALOPERIDOL; PERTUSSIS TOXIN; PHENTOLAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROPRANOLOL; QUINPIROLE; SULPIRIDE;

ANIMAL CELL; AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HYDROLYSIS; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE SLICE;

EID: 0029948069     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00179-3     Document Type: Article

References (32)

1. Abdel-Latif, A., 1986, Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers, Pharmacol. Rev. 38, 227.
2. Akera, T. and T. M. Brody, 1982, Myocardial membranes: regulation and function of the sodium pump, Ann. Rev. Physiol. 44, 375.
3. Aperia, A., B. Meister and T. Hokfest, 1991, Dopamine: an intrarenal hormone, in contemporary issues, in: Nephrology, eds. S. Goldfarb and F.N. Ziydeh (Churchill Livingstone, Inc., New York) p. 315.
4. Bernier, S. and G. Guillemette, 1993, Increased inositol 1,4,5-trisphosphate binding capacity in vascular smooth muscle of spontaneously hypertensive rats, Am. J. Hypertens. 6, 217.
5. Berridge, M.J., 1989, Inositol trisphosphate, calcium, lithium, and cell signaling, J. Am. Med. Assoc. 262, 1834.
6. +-pump, Part B: Cellular Aspects, eds. J. Skou, J. Norby, A. Mausebach and M. Esman (Alan Liss, New York) p. 353.
7. + -ATPase is an effector protein for protein kinase C in renal proximal tubule cells, Am. J. Physiol. 256, F370.
8. + -ATPase activity by dopamine, Am. J. Hypertens. 3, 51S.
9. 2 dopamine receptor synergism, Nature 347, 386.
10. Bonaccorsi, A.K., K. Hermsmeyer, O. Aprigliano, C.R. Smith and D.F. Bohr, 1977, Mechanism of potassium relaxation in arterial muscle, Blood Vessels 14, 261.
11. Felder, C.C., M. Blecher and P.A. Jose, 1989, Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes, J. Biol. Chem. 264, 8739.
12. Fleming, W.W., 1980, The electrogenic Na,K-pump in smooth muscle: physiologic and pharmacologic significance, Ann. Rev. Pharmacol. Toxicol. 20,129.
13. + ATPase and its mRNAs in a rat liver cell line, Am. J. Physiol. 258, C544.
14. Gonzales, R.A. and F.T. Crews 1985, Cholinergic- and adrenergic-stimulated inositide hydrolysis in brain interaction, regional distribution, and coupling mechanisms, J. Neurochem. 45, 1076.
15. Hamlyn, J.M., M.P. Blaustein, S. Bova, D.W. DuCharme, D.W. Harris, F. Mandel, W.R. Mathews and J.H. Ludens, 1991, Identification and characterization of a ouabain-like compound from human plasma, Proc. Natl. Acad. Sci. USA 88, 6259.
16. Hendrickx, H. and R. Casteels, 1974, Electrogenic sodium pump in arterial smooth muscle cells, Pflügers Arch. Fur. J. Physiol. 346, 299.
17. +-ATPase regulation by neurotransmitters, Neurochem. Int. 20, 1.
18. Jelicks, L.A. and R.K. Gupta, 1990, NMR measurement of cytosolic free calcium, free magnesium, and intracellular sodium in the aorta of the normal and spontaneously hypertensive rat, J. Biol. Chem. 265, 1394.
19. Johnson, M.D. and E. Friedman, 1993, G-proteins in cardiovascular function and dysfunction, Biochem. Pharmacol. 45, 2365.
20. + -ATPase in cultured epithelial cells, Am. J. Physiol. 251, C186.
21. Jose, P.A., J.R. Raymond, M.D. Bates, A. Aperia, R.A. Felder and R.M. Carey, 1991, The renal dopamine receptors, J. Am. Soc. Nephrol. 2, 1265.
22. Lang, S. and M.P. Blaustein, 1980, The role of the sodium pump in the control of vascular tone in the rat, Circ. Res. 46, 463.
23. Lowry, O.H., N.J. Rosenbrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193, 265.
24. Mulvany, M., 1985, Changes in sodium pump activity and vascular contraction, J. Hypertens. 3, 429.
25. +-ATPase activity, in: Methods in Enzymology. Vol. 156, part P (Academic Press) p. 116.
26. + -pump activity by dopamine in rat tail arteries, Eur. J. Pharmacol. 284, 289.
27. +-ATPase. 1. Role of cyclic AMP and phospholipase A2, J. Clin. Invest. 89, 1496.
28. + -ATPase activity, J. Clin. Invest. 77, 503.
29. Songu-Mize, E., S.L. Bealer and A.I. Hassid, 1990, Centrally administered ANF promotes appearence of a circulating sodium pump inhibitor, Am. J. Physiol. 258, H1655.
30. Uehara, Y., M. Ishii, T. Ishimitsu and T. Sugimoto, 1988, Enhanced phospholipase C activity in the vascular wall of spontaneously hypertensive rats, Hypertension 11, 28.
31. +-ATPase. Its endogenous ligands and neurotransmitter release, Neurochem. Int. 20, 11.
32. 2+ and intracellular proteins, Ann. Rev. Physiol. 50, 291.